Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVAVAX INC Director's Dealing 2010

Mar 17, 2010

31982_dirs_2010-03-17_6a3d2093-9dc3-4b44-9419-0ead17655886.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2010-03-15

Reporting Person: MCMANUS MICHAEL A JR (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-03-15 Options-right to buy $2.35 A 15000 Acquired 2020-03-15 Common Stock (15000) Direct

Footnotes

F1: Exercisable 6 months from date of grant.